ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Capital Reinvestment Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥288.83 Million) in capital expenditures (CN¥23.89 Million). See ZhuZhou QianJin Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ZhuZhou QianJin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks ZhuZhou QianJin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods.
Annual Capital Reinvestment Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see ZhuZhou QianJin Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥480.24 Million | CN¥124.17 Million | ▲ +117.9% |
| 2024 | 0.12x | CN¥398.77 Million | CN¥47.32 Million | ▲ +19.5% |
| 2023 | 0.10x | CN¥443.12 Million | CN¥43.99 Million | ▲ +111.5% |
| 2022 | 0.05x | CN¥733.47 Million | CN¥34.43 Million | ▼ -68.3% |
| 2021 | 0.15x | CN¥485.57 Million | CN¥71.88 Million | ▼ -17.4% |
| 2020 | 0.18x | CN¥542.37 Million | CN¥97.24 Million | ▼ -31.4% |
| 2019 | 0.26x | CN¥155.49 Million | CN¥40.61 Million | ▲ +115.9% |
| 2018 | 0.12x | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.2% |
| 2017 | 0.20x | CN¥283.47 Million | CN¥57.30 Million | ▼ -65.1% |
| 2016 | 0.58x | CN¥140.88 Million | CN¥81.50 Million | ▼ -53.8% |
| 2015 | 1.25x | CN¥67.48 Million | CN¥84.47 Million | ▲ +247.9% |
| 2014 | 0.36x | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥6.07 Million | CN¥59.24 Million | — |